Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Not Confirmed
Not Confirmed
17-21 January, 2026
Not Confirmed
Not Confirmed
21-22 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Industry Trade Show
Not Confirmed
17-21 January, 2026
Industry Trade Show
Not Confirmed
21-22 January, 2026
Digital content

15 Dec 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-12-15/pharmanovia-announces-launch-of-korjuny-catumaxomab-in-germany-a-first-in-class-treatment-for-mal

07 Oct 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/people/pharmanovia-appoints-stephan-eder-as-ceo-17948

01 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251001710846/en/Pharmanovia-Appoints-Stephan-Eder-as-Chief-Executive-Officer

13 Feb 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/lindis-biotech-and-pharmanovia-announce-european-marketing-authorizati-984539

02 Jan 2025
// ACCESSWIRE
https://www.accesswire.com/962075/radius-pharmaceuticals-announces-licensing-agreement-with-pharmanovia-to-register-and-commercialize-abaloparatide-in-china-and-select-asia-pacific-territories

19 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/944365/lindis-biotech-signs-licensing-agreement-with-pharmanovia-for-the-commercialization-of-catumaxomab
ABOUT THIS PAGE